IN8Bio

New York, United States

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

$20.1M raised

Dec 2025

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has IN8Bio raised?

IN8Bio has raised $20.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.

Who are IN8Bio's investors?

IN8Bio's investors include Coastlands Capital, Bios Partners, Stonepine Capital Management, 683 CAPITAL.

Where is IN8Bio headquartered?

IN8Bio is headquartered in New York, United States.

What does IN8Bio do?

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

What stage is IN8Bio at?

IN8Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2025.

MLA

"IN8Bio — Funding & Investors." VCBacked, December 19, 2025, https://www.vcbacked.co/company/in8bio. Accessed July 4, 2026.

APA

VCBacked. (2025). IN8Bio — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/in8bio

Wikipedia (cite web)

{{cite web |title=IN8Bio — Funding & Investors |url=https://www.vcbacked.co/company/in8bio |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2025.